Renalytix Plc (AIM:RENX)
4.150
0.00 (0.00%)
Aug 28, 2026, 5:15 PM GMT
Renalytix Revenue
Renalytix had revenue of $800.00K USD in the quarter ending December 31, 2025, with 36.52% growth. This brings the company's revenue in the last twelve months to $3.30M, up 40.31% year-over-year. In the fiscal year ending June 30, 2025, Renalytix had annual revenue of $3.00M with 30.43% growth.
Revenue (ttm)
$3.30M
Revenue Growth
+40.31%
P/S Ratio
7.40
Revenue / Employee
$71.74K
Employees
46
Market Cap
18.14M GBP
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 3.00M | 700.00K | 30.43% |
| Jun 30, 2024 | 2.30M | -1.10M | -32.41% |
| Jun 30, 2023 | 3.40M | 433.00K | 14.58% |
| Jun 30, 2022 | 2.97M | 1.48M | 99.20% |
| Jun 30, 2021 | 1.49M | - | - |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Craneware | 157.02M |
| Optima Health | 120.64M |
| Diaceutics | 38.44M |
| Cambridge Cognition Holdings | 9.40M |
| Feedback | 849.62K |
| Imaging Biometrics | 810.42K |
| Trellus Health | 262.03K |
Renalytix News
- 5 days ago - RenX Enterprises (RENX) Advances Organics Processing with New Microtec Turbo Mill - GuruFocus
- 16 days ago - RenX Enterprises (RENX) Sells Georgia Property to Fund Core Processing Platform Expansion - GuruFocus
- 20 days ago - RenX Enterprises (RENX) Outlines Strategic Plans Amid Challenging Valuation Metrics - GuruFocus
- 20 days ago - RenX Enterprises (RENX) Posts Record Q2 Revenue Amid Operational Expansion but Faces Valuation ... - GuruFocus
- 2 months ago - KidneyIntelX® Delivers Unprecedented Two-Year Real-World Outcomes in Diabetic Kidney Disease: No Comparable Risk Assessment Tool Exists - PRNewsWire
- 3 months ago - Renalytix™ and Carna Health Partner to Solve Kidney Disease Crisis: Bridging the Existing Gap Between Population Screening and Precision Intervention - PRNewsWire
- 5 months ago - Renalytix Quarterly report: H1 2026 - Filings
- 6 months ago - Renalytix Earnings release: H1 2026 - Filings